List of Flagship Pioneering patents

Patents where

Current Assignee

Name

Flagship Pioneering

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11376272 Methods of modulating immune activity	Patent 11376272 was granted and assigned to Flagship Pioneering on July, 2022 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11376272	July 5, 2022
‌ US Patent 11690387 Methods and related compositions for manufacturing food and feed	Patent 11690387 was granted and assigned to Flagship Pioneering on July, 2023 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11690387	July 4, 2023
‌ US Patent 11350648 Compositions and related methods for agriculture	Patent 11350648 was granted and assigned to Flagship Pioneering on June, 2022 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11350648	June 7, 2022
‌ US Patent 11576872 Compositions for facilitating membrane fusion and uses thereof	Patent 11576872 was granted and assigned to Flagship Pioneering on February, 2023 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11576872	February 14, 2023
‌ US Patent 11624065 Methods and compositions for modulating gene expression	Patent 11624065 was granted and assigned to Flagship Pioneering on April, 2023 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11624065	April 11, 2023
‌ US Patent 11274158 Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators	Patent 11274158 was granted and assigned to Flagship Pioneering on March, 2022 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11274158	March 15, 2022
‌ US Patent 10683352 Methods for treating cancer using GRM8 inhibitors	Patent 10683352 was granted and assigned to Flagship Pioneering on June, 2020 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	10683352	June 16, 2020
‌ US Patent 11446344 Anellovirus compositions and methods of use	Patent 11446344 was granted and assigned to Flagship Pioneering on September, 2022 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11446344	September 20, 2022
‌ US Patent 11058698 Acylated active agents and methods of their use for the treatment of autoimmune disorders	Patent 11058698 was granted and assigned to Flagship Pioneering on July, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11058698	July 13, 2021
‌ US Patent 10953027 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease	Patent 10953027 was granted and assigned to Flagship Pioneering on March, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	10953027	March 23, 2021
‌ US Patent 11312955 Methods and compositions for modulating gene expression	Patent 11312955 was granted and assigned to Flagship Pioneering on April, 2022 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11312955	April 26, 2022
‌ US Patent 11382950 Compositions and methods for cell delivery	Patent 11382950 was granted and assigned to Flagship Pioneering on July, 2022 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11382950	July 12, 2022
‌ US Patent 11471433 Postbiotic compositions and related methods for agriculture		Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11471433	October 18, 2022
‌ US Patent 10953033 Compositions comprising circular polyribonucleotides and uses thereof	Patent 10953033 was granted and assigned to Flagship Pioneering on March, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	10953033	March 23, 2021
‌ US Patent 11166996 Anellovirus compositions and methods of use	Patent 11166996 was granted and assigned to Flagship Pioneering on November, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11166996	November 9, 2021
‌ US Patent 11458156 Compositions comprising circular polyribonucleotides and uses thereof		Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11458156	October 4, 2022
‌ US Patent 11058706 Compositions comprising circular polyribonucleotides and uses thereof	Patent 11058706 was granted and assigned to Flagship Pioneering on July, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11058706	July 13, 2021
‌ US Patent 11160822 Compositions comprising circular polyribonucleotides and uses thereof	Patent 11160822 was granted and assigned to Flagship Pioneering on November, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11160822	November 2, 2021
‌ US Patent 11013717 Methods and compositions for treating cancer using SERCA pump inhibitors	Patent 11013717 was granted and assigned to Flagship Pioneering on May, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11013717	May 25, 2021
‌ US Patent 11059886 Methods and compositions for treating inflammatory or autoimmune diseases or conditions using GRM8 activators	Patent 11059886 was granted and assigned to Flagship Pioneering on July, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11059886	July 13, 2021
‌ US Patent 11034751 Methods and compositions for treating cancer using serotonin receptor inhibitors	Patent 11034751 was granted and assigned to Flagship Pioneering on June, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11034751	June 15, 2021
‌ US Patent 11208475 Methods and compositions for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activators	Patent 11208475 was granted and assigned to Flagship Pioneering on December, 2021 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11208475	December 28, 2021
‌ US Patent 10457740 Methods and compositions for treating cancer using P2RX2 inhibitors	Patent 10457740 was granted and assigned to Flagship Pioneering on October, 2019 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	10457740	October 29, 2019
‌ US Patent 11788152 Multiple-tiered screening and second analysis	Patent 11788152 was granted and assigned to Flagship Pioneering on October, 2023 by the United States Patent and Trademark Office.	Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11788152	October 17, 2023
‌ US Patent 11654121 Combination therapies for the treatment of viral infections		Flagship Pioneering	Flagship Pioneering	United States Patent and Trademark Office	11654121	May 23, 2023

Results per page:

25 results

0 selected

25 results

0 selected